Sep 2026· Eurasian Clinical and Analytical Medicine· Vol 14, pp. 95-98· 0 citations· 12 references
TL;DR
A rare case of thyroid metastasis detected 27 years after the initial diagnosis of BC with subsequent pulmonary, cervical lymph node, and skeletal metastases, highlighting the importance of considering metastatic disease in newly detected thyroid nodules, even decades after the initial diagnosis of breast cancer.
Abstract
Introduction
Breast cancer (BC) most frequently metastasizes to bone, lung, and brain, whereas thyroid involvement is rare. We report a rare case of thyroid metastasis detected 27 years after the initial diagnosis of BC with subsequent pulmonary, cervical lymph node, and skeletal metastases.
Case Presentation
A 72-year-old woman diagnosed in 1997 with stage IIA, ER-positive, PR-positive, HER2-negative invasive ductal carcinoma underwent modified radical mastectomy followed by adjuvant therapy. After 27 disease-free years, a thyroid nodule was detected. Fine-needle aspiration suggested malignancy, and total thyroidectomy was performed. Immunohistochemistry showed GATA3, ER, and PR positivity with negative HER2, TTF-1, and thyroglobulin, confirming metastatic BC. PET-CT revealed cervical lymph node, pulmonary, and skeletal metastases. The patient received ribociclib, letrozole, and denosumab, with a favorable response at one-year follow-up.
Conclusion
This case highlights the importance of considering metastatic disease in newly detected thyroid nodules, even decades after the initial diagnosis of breast cancer.
Background: In patients with metastatic breast carcinoma, newly identified visceral or pulmonary lesions may represent progression of the known malignancy or, less commonly, a distinct second primary tumor. Histopathological and immunohistochemical evaluation is therefore essential for establishing tumor lineage and gu...
Adeline R. Bucur, Alexandru Cristian Cindrea, P. Curescu et al.· Diagnostics· 0 citations
Although thyroid metastasis from colorectal carcinoma (CRC) is exceedingly rare, with a reported clinical incidence of ~0.1-0.3%, its detection typically signifies advanced-stage systemic disease. This atypical metastatic pattern generally correlates with a terminal stage and a historically poor prognosis, with a repor...
Jie Chen, An-Sheng Wang, Lin-Ting Guo et al.· Biomedical Reports· 0 citations
This case illustrates how a decade-long latency, mixed histomorphology, and a high-risk molecular profile can complicate the recognition of anaplastic transformation, and underscores the diagnostic and therapeutic pathway required for optimal management.
G. Durham, Cindy Almaraz, C. Steinman et al.· World Journal of Biology Pha...· 0 citations
Introduction: Mixed medullary and follicular-cell derived carcinoma (MMFCC) is an exceptionally rare thyroid malignancy, accounting for less than 0.1% of all thyroid malignancies, defined by the coexistence of morphologically distinct follicular and C-cell-derived populations. Diagnosis is difficult when bone metastasi...
Ignatius Ferdi Yuatmadja, H. Saputra· Indonesian Journal of Cancer· 0 citations
We describe a case of breast metastasis originating from a small-cell neuroendocrine carcinoma (SCNEC) of the uterine cervix, an uncommon presentation that can be difficult to distinguish from a primary breast malignancy. We report a 29-year-old woman treated three years earlier for FIGO stage IB2 cervical SCNEC with c...
G. Bruyninx, E. Patocskai, Lilia Maria Sanchez et al.· Cureus· 0 citations
Recurrence of papillary thyroid cancer (PTC) beyond three decades after definitive treatment is a rare clinical event. We report a case of a 69-year-old male with PTC who had undergone near-total thyroidectomy and radioiodine remnant ablation thirty years ago, with an initial low risk of recurrence. He had an excelle...
K. Chandekar, S. Ravindra, N. Damle et al.· Indian Journal of Nuclear Me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.